Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.
King GD; Kroeger KM; Bresee CJ; Candolfi M; Liu C; Manalo CM; Muhammad AK; Pechnick RN; Lowenstein PR; Castro MG; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2008, vol. 16, issue 4, p 682, ISSN 15250024. ISBN 15250024.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef